Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference
MALVERN, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
Read moreMALVERN, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
Read moreRise in people looking to eliminate excess fat is fueling the Liposuction Surgery Devices Market. Medical tourism and the growing...
Read moreATLANTA, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a leading global engineering design and manufacturer...
Read moreGSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b multiple ascending dose study Significant weight...
Read moreEco-Friendly and Organic Feminine Hygiene Products Gain Popularity Among Consumers, Driving Growth in the MarketNew York, Sept. 29, 2023 (GLOBE...
Read moreStephen Dilly Headshot Stephen Dilly, MBBS, PhD, President & CEO of Codexis, Inc. REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE...
Read moreCAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically...
Read moreCANACA Introduces New Flower Offerings and Infused Pre-roll LineupTORONTO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or...
Read moreA10765 Currently Sampling and Meets the Stringent Coexistence Requirements for 5 GHz U-NII 1-3 BandsProduction Ramp Expected to Begin in...
Read moreGREENWICH, Conn. , Sept. 29, 2023 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO) will hold its third quarter conference call and webcast on...
Read more